Skip to main content

Advertisement

SpringerLink
Log in

BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

BRCA1 mutations have been associated with hereditary breast cancer only. Recent studies indicate that a subgroup of sporadic breast cancer might also be associated with reduction in BRCA1 mRNA levels and protein expression. However, the mechanism of reduced mRNA and protein expression is yet not fully elucidated. This study aims to assess BRCA1 protein expression and the role of BRCA1 promoter methylation in sporadic breast cancer in North Indian population and to correlate these with known prognostic factors and molecular profiles of breast cancer. BRCA1 protein expression was normal (>50 % tumour cells) in 41 (43 %) cases, reduced (20–50 % tumour cells) in 33 (35 %) cases and absent/markedly reduced (<20 % tumour cells) in 21 (22.1 %) cases. Cases which were negative for BRCA1 protein were more frequently positive for basal markers (29 versus 5 %) and were more often ER-negative (62 versus 39 %) than BRCA1-positive tumours. Methylation of BRCA1 promoter region was seen in 11/45 cases (24 %). All 11 cases showing BRCA1 methylation had absent (eight cases) or reduced (three cases) BRCA1 protein expression. BRCA1 protein-negative tumours were more frequently basal marker-positive and ER-negative, highlighting the ‘BRCAness’ of sporadic breast cancer with loss of BRCA1 protein expression through promoter hypermethylation similar to hereditary breast cancer with BRCA1 mutations. Loss of BRCA1 in sporadic breast cancer suggests that therapeutics targeting BRCA1 pathway in hereditary breast cancer like PARP inhibitors might be used as therapeutic targets for sporadic breast tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Easton DF, Bishop DT, Ford D (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52:678–701

    PubMed  CAS  Google Scholar 

  2. Claus EB, Schildkraut JM, Thompson WD (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–2324

    Article  PubMed  CAS  Google Scholar 

  3. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120–122

    Article  PubMed  CAS  Google Scholar 

  4. Lancaster JM, Wooster R, Mangion J et al (1996) BRCA2 mutations in primary breast and ovarian cancers. Nat Genet 13:238–240

    Article  PubMed  CAS  Google Scholar 

  5. Johnson SM, Shaw JA, Walker RA (2002) Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. Int J Cancer 98:205–209

    Article  PubMed  CAS  Google Scholar 

  6. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042–2054

    Article  PubMed  CAS  Google Scholar 

  7. Kim MJ, Ro JY, Ahn SH et al (2006) Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neuoverexpressing phenotypes. Hum Pathol 37:1217–1226

    Article  PubMed  CAS  Google Scholar 

  8. DeVargas RL, Michor F (2011) Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis. J Theor Biol 273:207–215

    Article  Google Scholar 

  9. Valentin MD, da Silva SD, Privat M, Alaoui-Jamali M, Bignon YB (2012) Molecular insights on basal-like breast cancer. Breast Canc Res Treat 2012 Jan 11 [Epub ahead of print]

  10. Santarosa M, Maestro R (2012) BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype. Cancer Metastasis Rev 31:131–142

    Article  PubMed  Google Scholar 

  11. Warmoes M, Jaspers JE, Pham TV et al (2012) Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with diagnostic and prognostic value in human breast cancer. Mol Cell Proteomics 2012 Feb 24 [Epub ahead of print]

  12. Da Pang, Zhao Y, Xue W et al (2011) Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese. Med Oncol 2011 Nov 11 [Epub ahead of print]

  13. Ibragimova I, Cairns P (2011) Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy. Meth Mol Biol 780:277–291

    Article  CAS  Google Scholar 

  14. Jaspers JE, Rottenberg S, Jonkers J (2009) Therapeutic options for triple negative breast cancers with defective homologous recombination. Biochim Biophys Acta 1796:266–280

    PubMed  CAS  Google Scholar 

  15. Tutt A, Robson M, Garber JE et al (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof of-concept trial. Lancet 376:235–244

    Article  PubMed  CAS  Google Scholar 

  16. Taylor J, Lymboura M, Pace PE et al (1998) An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int J Cancer 79:334–342

    Article  PubMed  CAS  Google Scholar 

  17. Rakha EA, El-Sheikh SE, Kandil MA et al (2008) Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol 39:857–865

    Article  PubMed  CAS  Google Scholar 

  18. Lambie H, Miremadi A, Pinder SE et al (2003) Prognostic significance of BRCA1 expression in sporadic breast carcinomas. J Pathol 200:207–213

    Article  PubMed  CAS  Google Scholar 

  19. Nielsen TO, Hsu FD, Jensen K (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367–5374

    Article  PubMed  CAS  Google Scholar 

  20. Abd El-Rehim DM, Pinder SE, Paish CE (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203:661–671

    Article  PubMed  Google Scholar 

  21. Foulkes WD, Ingunn MS, Chappuis PO et al (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95:19

    Article  Google Scholar 

  22. Singha AK, Pandey A, Tewarib M, Shukla HS, Pandey HP (2011) Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population. Eur J Cancer Prev 20:478–483

    Article  Google Scholar 

  23. Ben GR, Hachana M, Ziadi S et al (2011) Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients. Canc Epidemiol Oct 4, (Epub ahead of print)

  24. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428

    Article  PubMed  CAS  Google Scholar 

  25. Birgisdottir V, Stefansson OA (2006) Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res 8:R38

    Article  PubMed  Google Scholar 

  26. Foulkes WD, Stefansson IM, Chappuis PO et al (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95:1482–1485

    Article  PubMed  CAS  Google Scholar 

  27. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427–5440

    Article  PubMed  CAS  Google Scholar 

  28. Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer: a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107–116

    Article  PubMed  CAS  Google Scholar 

  29. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564–569

    Article  PubMed  CAS  Google Scholar 

  30. Xu CF, Brown MA, Chambers JA et al (1995) Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum Mol Genet 4:2259–2264

    Article  PubMed  CAS  Google Scholar 

  31. Catteau A, Morris JR (2002) BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol 12:359–371

    Article  PubMed  CAS  Google Scholar 

  32. Mirza S, Sharma G, Prasad CP et al (2007) Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 81:280–287

    Article  PubMed  CAS  Google Scholar 

  33. Raju Bagadi SA, Prasad CP, Kaur J et al (2008) Clinical significance of promoter hypermethylation of RASSF1A, RARβ2, BRCA1 and HOXA5 in breast cancers of Indian patients. Life Sci 82:1288–1292

    Article  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no financial or non-financial conflict of interests.

Author information

Authors and Affiliations

  1. Department of Histopathology, Post Graduate Institute of Medical Sciences & Research (PGIMER), Sector 12, Chandigarh, 160012, India

    Amanjit Bal, Sangeeta Verma, Kusum Joshi & Ravi Thakur

  2. Department of Immunopathology, Post Graduate Institute of Medical Sciences & Research (PGIMER), Sector 12, Chandigarh, 160012, India

    Anuj Singla & Sunil Arora

  3. Department of General Surgery, Post Graduate Institute of Medical Sciences & Research (PGIMER), Sector 12, Chandigarh, 160012, India

    Gurpreet Singh

Authors
  1. Amanjit Bal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sangeeta Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kusum Joshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anuj Singla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ravi Thakur
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sunil Arora
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gurpreet Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amanjit Bal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bal, A., Verma, S., Joshi, K. et al. BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression. Virchows Arch 461, 305–312 (2012). https://doi.org/10.1007/s00428-012-1286-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-012-1286-z

Keywords

Search

Navigation